Ken Griffin Amedisys Inc Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$90.4 - $96.77 $99,440 - $106,447	1,100 Added 33.33%	4,400 $403,000
Q1 2024 May 15, 2024	BUY	$92.15 - $95.24 $73,720 - $76,192	800 Added 32.0%	3,300 $304,000
Q4 2023 Feb 14, 2024	BUY	$91.15 - $95.89 $91,150 - $95,890	1,000 Added 66.67%	2,500 $237,000
Q3 2023 Nov 14, 2023	SELL	$89.84 - $94.08 $80,856 - $84,672	-900 Reduced 37.5%	1,500 $140,000
Q2 2023 Aug 14, 2023	SELL	$73.99 - $92.6 $1.18 Million - $1.47 Million	-15,900 Reduced 86.89%	2,400 $219,000
Q1 2023 May 15, 2023	SELL	$69.79 - $100.33 $565,299 - $812,673	-8,100 Reduced 30.68%	18,300 $1.35 Million
Q4 2022 Feb 14, 2023	SELL	$80.12 - $105.34 $777,164 - $1.02 Million	-9,700 Reduced 26.87%	26,400 $2.21 Million
Q3 2022 Nov 14, 2022	SELL	$96.79 - $131.14 $1.14 Million - $1.55 Million	-11,800 Reduced 24.63%	36,100 $3.49 Million

310

29.8M

203K

1.18M

Ticker AMED
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 32,492,000
Market Cap $3.15B
Description
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.